Gross Profit Comparison: Bio-Techne Corporation and Bausch Health Companies Inc. Trends

Biotech vs. Healthcare: A Decade of Gross Profit Trends

__timestampBausch Health Companies Inc.Bio-Techne Corporation
Wednesday, January 1, 20146008900000251411000
Thursday, January 1, 20157853800000307277000
Friday, January 1, 20167063000000336659000
Sunday, January 1, 20176176000000374541000
Monday, January 1, 20186029000000432143000
Tuesday, January 1, 20196251000000473491000
Wednesday, January 1, 20205778000000483194000
Friday, January 1, 20216040000000632850000
Saturday, January 1, 20225760000000756496000
Sunday, January 1, 20236198000000769815000
Monday, January 1, 2024769725000
Loading chart...

Unlocking the unknown

Gross Profit Trends in the Biotech and Healthcare Sectors

In the ever-evolving landscape of the biotech and healthcare industries, understanding financial trends is crucial. This analysis focuses on the gross profit trajectories of Bio-Techne Corporation and Bausch Health Companies Inc. from 2014 to 2023.

Bio-Techne Corporation

Bio-Techne has shown a remarkable upward trend, with gross profits increasing by over 200% from 2014 to 2023. This growth highlights the company's strategic advancements and robust market positioning, especially in the latter half of the decade.

Bausch Health Companies Inc.

Conversely, Bausch Health's gross profit has experienced fluctuations, peaking in 2015 and then stabilizing around a 10% lower average in subsequent years. This pattern reflects the challenges faced in the competitive healthcare market.

Overall, while Bio-Techne's consistent growth underscores its innovative edge, Bausch Health's performance suggests a need for strategic recalibration to regain its former financial heights.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025